Editorial

The Big Data Revolution for Breast Cancer Patients
  • Issam Ibnouhsein
  • Stéphane Jankowski
  • Karl Neuberger
  • Carole Mathelin
Eur J Breast Health 2018; 14: 61-62 DOI: 10.5152/ejbh.2018.0101

Original Article

Diagnostic Value of Axillary Ultrasound, MRI, and 18F-FDG-PET/ CT in Determining Axillary Lymph Node Status in Breast Cancer Patients
  • Ayşegül Aktaş
  • Meryem Günay Gürleyik
  • Sibel Aydın Aksu
  • Fugen Aker
  • Serkan Güngör
Eur J Breast Health 2022; 18: 37-47 DOI: 10.4274/ejbh.galenos.2021.2021-3-10 PMID:35059590
Survival Analysis of Triple Negative and Her2 Positive Breast Cancer Patients: Single Center Report
  • Umut Varol
  • Burcu Çakar
  • İbrahim Yıldız
  • Ceyda Tunakan Dalgıç
  • Hatice Özışık
  • Melih Özışık
  • Burçak Karaca
  • Bülent Karabulut
  • Rüçhan Uslu
Eur J Breast Health 2014; 10: 42-46 DOI: 10.5152/tjbh.2014.1773
An In Silico Analysis Identified FZD9 as a Potential Prognostic Biomarker in Triple-Negative Breast Cancer Patients
  • Daniel Rodrigues de Bastos
  • Mércia Patrícia Ferreira Conceição
  • Ana Paula Picaro Michelli
  • Jean Michel Rocha Sampaio Leite
  • Rafael André da Silva
  • Ricardo Cesar Cintra
  • Jeniffer Johana Duarte Sanchez
  • Cesar Augusto Sam Tiago Vilanova-Costa
  • Antonio Márcio Teodoro Cordeiro Silva
Eur J Breast Health 2021; 17: 42-52 DOI: 10.4274/ejbh.2020.5804 PMID:33796830
Efficacy of the Radiofrequency Identification Technique in Breast Cancer Patients: A Single Institution Retrospective Study
  • Mahmoud Kassem
  • Ahmed Kamr
  • Creighton B. Wright
  • Anna P. Sobolewski
Eur J Breast Health 2024; 20: 52-56 DOI: 10.4274/ejbh.galenos.2023.2023-10-9 PMID:38187107
Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience
  • Roshankumar Patil
  • Prakash Pandit
  • Vijay Palwe
  • Shruti Kate
  • Sucheta Gandhe
  • Rahul Patil
  • Yasam Venkata Ramesh
  • Raj Nagarkar
Eur J Breast Health 2021; 17: 62-67 DOI: 10.4274/ejbh.2020.5969 PMID:33796832
Post Mastectomy Radiation for Stage II Breast Cancer Patients with T1/T2 Lesions
  • Shai Libson
  • Eduardo Perez
  • Christiane Takita
  • Eli Avisar
Eur J Breast Health 2019; 15: 71-75 DOI: 10.5152/ejbh.2019.4481
The Impact of the COVID-19 Pandemic on Breast Cancer Patients
  • Ahmet Serkan İlgün
  • Vahit Özmen
Eur J Breast Health 2022; 18: 85-90 DOI: 10.4274/ejbh.galenos.2021.2021-11-5 PMID:35059596
Comparison of MRI and US in Tumor Size Evaluation of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
  • Onur Taydaş
  • Gamze Durhan
  • Meltem Gülsün Akpınar
  • Figen Başaran Demirkazık
Eur J Breast Health 2019; 15: 119-124 DOI: 10.5152/ejbh.2019.4547
Comparison of Clinical and Pathological Differences of Breast Cancer Patients under 35 and above 55 Years of Age
  • Mustafa Emiroğlu
  • Cem Karaali
  • İsmail Sert
  • Semra Salimoğlu
  • Levent Uğurlu
  • Süleyman Aksoy
  • Cengiz Aydın
Eur J Breast Health 2015; 11: 123-127 DOI: 10.5152/tjbh.2015.2539
Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine
  • İzzet Doğan
  • Nail Paksoy
  • Naziye Ak
  • Sezai Vatansever
  • Pınar Saip
  • Adnan Aydıner
Eur J Breast Health 2023; 19: 128-133 DOI: 10.4274/ejbh.galenos.2023.2022-12-4 PMID:37025570
Predictors of Unilateral Arm Lymphedema in Non-obese Locoregionally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy, Modified Radical Mastectomy, and Postoperative Irradiation
  • Surjeet Dwivedi
  • Amiy Arnav
  • Varun Kumar Agarwal
  • S K Deshpande
  • Rohit Sharma
  • Naresh Saidha
Eur J Breast Health 2024; 20: 149-155 DOI: 10.4274/ejbh.galenos.2024.2024-1-11
The Effect of Mini-Latissimus Dorsi Flap (MLDF) Reconstruction on Shoulder Function in Breast Cancer Patients
  • Tomris Duymaz
  • Zeynep Erdoğan İyigün
  • Ahmet Serkan İlgün
  • Çetin Ordu
  • Muhammed Üçüncü
  • Gül Alço
  • Alper Öztürk
  • Filiz Elbüken
  • Fatma Aktepe
  • Vahit Özmen
Eur J Breast Health 2019; 15: 158-162 DOI: 10.5152/ejbh.2019.4727
The Oncotype Dx Assay in ER-Positive, HER2-Negative Breast Cancer Patients: A Real Life Experience from a Single Cancer Center
  • Stephane Thibodeau
  • Ioannis A. Voutsadakis
Eur J Breast Health 2019; 15: 163-170 DOI: 10.5152/ejbh.2019.4901
The Benefit of Routine Axillary Sonographic Assessment in cN0 Breast Cancer Patients
  • Marian Khatib
  • Panagiotis Sgardelis
  • Schlomo Schneebaum
  • Ortal Schaffer
  • Richard Sutton
Eur J Breast Health 2022; 18: 163-166 DOI: 10.4274/ejbh.galenos.2022.2021-11-6 PMID:35445178
Use of Alternative Medicine Is Delaying Health-Seeking Behavior by Bangladeshi Breast Cancer Patients
  • Khursheda Akhtar
  • Khodeza Akhtar
  • M. Mizanur Rahman
Eur J Breast Health 2018; 14: 166-172 DOI: 10.5152/ejbh.2018.3929
Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients
  • Özlem Özdemir
  • Baha Zengel
  • Demet Kocatepe Çavdar
  • Cengiz Yılmaz
  • Raika Durusoy
Eur J Breast Health 2022; 18: 167-171 DOI: 10.4274/ejbh.galenos.2022.2022-1-4 PMID:35445177
Evaluation of the Probability of Non-sentinel Lymph Node Metastasis in Breast Cancer Patients with Sentinel Lymph Node Metastasis using Two Different Methods
  • İrfan Başoğlu
  • Muhammet Ferhat Çelik
  • Ahmet Cem Dural
  • Mustafa Gökhan Ünsal
  • Cevher Akarsu
  • Halil Fırat Baytekin
  • Selin Kapan
  • Halil Alış
Eur J Breast Health 2015; 11: 172-179 DOI: 10.5152/tjbh.2015.2686
Associated Features with Non-Sentinel Lymph Node Involvement in Early Stage Breast Cancer Patients who Have Positive Macrometastatic Sentinel Lymph Node
  • Hakan Ataş
  • Buket Altun Özdemir
  • Ebru Menekşe
  • Sabri Özden
  • Yunus Nadi Yüksek
  • Gül Dağlar
Eur J Breast Health 2020; 16: 192-197 DOI: 10.5152/ejbh.2020.5332
Axillary Boost Technique on Adjuvant Regional Lymph Node Irradiation in Breast Cancer Patients
  • Serap Çatlı
  • Fatih Demircioğlu
  • Diclehan Kılıç
  • Sevilay İren
Eur J Breast Health 2013; 9: 205-209 DOI: 10.5152/tjbh.2013.34
Evaluation of Pathologic Complete Response (pCR) to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients with Estrogen Receptor Positive and HER2 Negative and impact of predicting variables on pCR
  • Ramesh Omranipour
  • Roghiyeh Jalili
  • Adel Yazdankhahkenary
  • Abdolali Assarian
  • Mehrzad Mirzania
  • Bita Eslami
Eur J Breast Health 2020; 16: 213-218 DOI: 10.5152/ejbh.2020.5487
Assessment of the Quality of Life in Turkish Breast Cancer Patients
  • İbrahim Yıldız
  • Umut Varol
  • Ahmet Alacacıoğlu
Eur J Breast Health 2014; 10: 216-221 DOI: 10.5152/tjbh.2014.2012
Impact of Surgery Type on Quality of Life in Breast Cancer Patients
  • Mustafa Akça
  • Alper Ata
  • Erdinç Nayır
  • Süleyman Erdoğdu
  • Ali Arıcan
Eur J Breast Health 2014; 10: 222-228 DOI: 10.5152/tjbh.2014.1919
Correlation between the Expression of PD-L1 and Clinicopathological Parameters in Triple Negative Breast Cancer Patients
  • Rabia Doğukan
  • Ramazan Uçak
  • Fatih Mert Doğukan
  • Canan Tanık
  • Bülent Çitgez
  • Fevziye Kabukcuoğlu
Eur J Breast Health 2019; 15: 235-241 DOI: 10.5152/ejbh.2019.4912
An In Silico Analysis Identified Members of the Pleckstrin Homology-Like Domain, Family B (PHLDB family) as Potential Prognostic and Predictive Biomarkers of Treatment Response in Breast Cancer Patients
  • Renan Gomes do Nascimento
  • Jéssica de Moraes
  • Danilo de Oliveira Cerqueira
  • Sandro Jorge Januário
Eur J Breast Health 2022; 18: 235-247 DOI: 10.4274/ejbh.galenos.2022.2022-3-5 PMID:35855195
Lymph Node Ratio (LNR): Predicting Prognosis after Neoadjuvant Chemotherapy (NAC) in Breast Cancer Patients
  • Atilla Soran
  • Tolga Ozmen
  • Arsalan Salamat
  • Gürsel Soybir
  • Ronald Johnson
Eur J Breast Health 2019; 15: 249-255 DOI: 10.5152/ejbh.2019.4848
Clinical Significance of Radiologically Detected Small Indeterminate Extra-Mammary Lesions in Breast Cancer Patients
  • Rachel Yanlin Chen
  • Rui Ying Goh
  • Hoi Ting Leung
  • Stephanie Cheng
  • Veronique Kiak Mien Tan
  • Clement Luck Khng Chia
  • Jerry Tiong Thye Goo
  • Marc Weijie Ong
Eur J Breast Health 2022; 18: 252-257 DOI: 10.4274/ejbh.galenos.2022.2022-1-2 PMID:35855201
How Do Breast Cancer Patients Present Following COVID-19 Early Peak in a Breast Cancer Center in Turkey?
  • Aysun Dauti Işıklar
  • Cem Deniz
  • Aykut Soyder
  • Nilgün Güldoğan
  • Ebru Yılmaz
  • Gül Başaran
Eur J Breast Health 2021; 17: 253-257 DOI: 10.4274/ejbh.galenos.2021.6161 PMID:34263153
Colour Coding Navigation: “Triage” Techniques to Improve Compliance in Breast Cancer Patients Requiring Primary Chemotherapy
  • Carol Ann Benn
  • Yastira Ramdas
  • Barend van den Bergh
  • Naa-Lamle Bannerman
  • Dominic van Loggerenberg
  • Tia van Loggerenberg
  • Vernon Shaw
Eur J Breast Health 2020; 16: 262-266 DOI: 10.5152/ejbh.2020.5784
Does a 40% Cut-off Point for Ki-67 Expression Have a Role in Identifying the Development of Distant Metastasis Within 2 Years in Locally Advanced Triple Negative Breast Cancer Patients?
  • Kelvin Setiawan
  • Ida Bagus Suryawisesa
  • I Ketut Widiana
  • I Wayan Sudarsa
Eur J Breast Health 2023; 19: 274-278 DOI: 10.4274/ejbh.galenos.2023.2023-4-5 PMID:37794999
Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients
  • İzzet Doğan
  • Esra Aydın
  • Hülya Yazıcı
  • Pınar Saip
Eur J Breast Health 2022; 18: 323-328 DOI: 10.4274/ejbh.galenos.2022.2022-5-2 PMID:36248747

Review

Extended Sentinel Node Biopsy in Breast Cancer Patients who Achieve Complete Nodal Response with Neoadjuvant Chemotherapy
  • Alfredo Carlos Simões Dornellas de Barros
  • Danúbia Ariana de Andrade
Eur J Breast Health 2020; 16: 99-105 DOI: 10.5152/ejbh.2020.4730
BREAST CARE AND CANCER NURSING: AN EXAMPLE FROM THE GERMAN-SPEAKING COUNTRIES
  • Beyhan Bağ
  • Nesrin Reis
Eur J Breast Health 2013; 9: 111-117 DOI: 10.5152/tjbh.2013.16